2 hypotheses on the adverse reaction to the anti-Covid Astrazeneca vaccine. Talk about Lorenzo (Irbm)
What he said to Coffee Break, the broadcast of La7 conducted by Andrea Pancani, Pietro Di Lorenzo of the Irbm company
The woman who had an adverse reaction in the clinical phase 3 tests of the vaccine developed by AstraZeneca and the University of Oxford in collaboration with the Italian Irbm may not have been vaccinated. To support him, speaking at Coffee Break, the La7 program conducted by Andrea Pancani, is Piero Di Lorenzo, president of the Pomezia company.
WAS THE WOMAN VACCINATED?
The woman who had an adverse reaction to AstraZeneca's Covid-19 vaccine "may have not been vaccinated," Di Lorenzo told Coffee Break .
To establish this, explains the president of Irbm, will be the "independent commission in England that meets from today". The experts will assess "if she was vaccinated, if the event to which she was subjected depends on the vaccine or is absolutely independent and vaccination is indifferent to this case", explained Di Lorenzo.
DOUBLE BLIND VACCINATION
How is it possible that it is not known if the woman ( the gender of the volunteer was revealed by the CEO of Astrazeneca in an interview with the Guardian ) was vaccinated? The question is simple: “To be sure that there is no placebo effect, we vaccinate in a double-blind manner”, explains Di Lorendo. "One half receives placebo inoculation, another half receives the vaccine", but what is up to those who "neither volunteers nor scientists know".
WHAT HAPPENED
At this point, let's take a step back. Astrazeneca, after an adverse reaction, has suspended worldwide testing of the vaccine – currently in clinical phase 3 – developed in collaboration with the University of Oxford and Irbm of Pomezia .
PAIN OR CROSS MYELITE?
What is the adverse reaction? "Pain," Di Lorenzo told Coffee Break . "There is no diagnosis, these pains have led to an alert".
THE THESIS OF THE NYT
For the New York Times , which revealed that the volunteer was participating in the UK in phase 2/3 of the vaccine trial he suddenly presented cross myelitis, an inflammation that affects the spinal cord and is often triggered by viral infections. .
PLATEA
In all this, it must be emphasized that the "audience of volunteers enrolled (50,000 in this case, ed ) of phase three are volunteers and some have previous diseases, even serious ones", added Di Lorenzo: "It is therefore physiological an alert , it's routine ".
"The protocol, in the event of an alert, requires that the regulatory agency be notified immediately, so that an independent scientific commission can verify". And the Commission will now give all the answers.
This is a machine translation from Italian language of a post published on Start Magazine at the URL https://www.startmag.it/innovazione/2-ipotesi-sulla-reazione-avversa-al-vaccino-astrazeneca-anti-covid-parla-di-lorenzo-irbm/ on Fri, 11 Sep 2020 14:50:28 +0000.